{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T21:10:15Z","timestamp":1759093815772,"version":"3.44.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005688","name":"Gottfried und Julia Bangerter-Rhyner-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005688","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.ijcard.2011.01.033","type":"journal-article","created":{"date-parts":[[2011,2,5]],"date-time":"2011-02-05T04:23:14Z","timestamp":1296879794000},"page":"93-100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Updated evidence on early statin therapy for acute coronary syndromes: Meta-analysis of 18 randomized trials involving over 14,000 patients"],"prefix":"10.1016","volume":"158","author":[{"given":"Matthias","family":"Briel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noah","family":"Vale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory G.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James A.","family":"de Lemos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Furio","family":"Colivicchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank R.","family":"den Hartog","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petr","family":"Ostadal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stella M.","family":"Macin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anho","family":"Liem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ed","family":"Mills","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neera","family":"Bhatnagar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heiner C.","family":"Bucher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain J.","family":"Nordmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2011.01.033_bb0005","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1001\/archinte.165.7.725","article-title":"Effect of different antilipidemic agents and diets on mortality: a systematic review","volume":"165","author":"Studer","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijcard.2011.01.033_bb0010","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.amjmed.2004.04.022","article-title":"Effects of statins on stroke prevention in patients with and without coronary heart disease: a meta-analysis of randomized controlled trials","volume":"117","author":"Briel","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.ijcard.2011.01.033_bb0015","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90, 056 participants in 14 randomised trials of statins","volume":"366","author":"Baigent","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2011.01.033_bb0020","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1001\/jama.295.17.2046","article-title":"Effects of early treatment with statins on short-term clinical outcomes in acute coronary syndromes: a meta-analysis of randomized controlled trials","volume":"295","author":"Briel","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2011.01.033_bb0025","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1001\/archinte.166.17.1814","article-title":"The effect of early, intensive statin therapy on acute coronary syndrome: a meta-analysis of randomized controlled trials","volume":"166","author":"Hulten","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijcard.2011.01.033_bb0030","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1053\/euhj.1998.1243","article-title":"Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention","volume":"19","author":"Wood","year":"1998","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijcard.2011.01.033_bb0035","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1161\/01.ATV.0000032033.39301.6A","article-title":"Statin therapy in acute coronary syndromes: mechanistic insight into clinical benefit","volume":"22","author":"Sposito","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ijcard.2011.01.033_bb0040","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0002-9149(97)00963-6","article-title":"Rationale and design of the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) study that evaluates atorvastatin in unstable angina pectoris and in non-Q-wave acute myocardial infarction","volume":"81","author":"Schwartz","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijcard.2011.01.033_bb0045","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.jacc.2009.04.093","article-title":"Statins in acute coronary syndromes: do the guideline recommendations match the evidence?","volume":"54","author":"Morrissey","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2011.01.033_bb0050","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Intensive versus moderate lipid lowering with statins after acute coronary syndromes","volume":"350","author":"Cannon","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2011.01.033_bb0055","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jacc.2009.04.033","volume":"54","author":"Hiro","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2011.01.033_bb0060","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.jacc.2007.11.075","article-title":"Lipid levels after acute coronary syndromes","volume":"51","author":"Pitt","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2011.01.033_bb0065","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1185\/03007991003751496","article-title":"Full-dose atorvastatin versus conventional medical therapy after non-ST-elevation acute myocardial infarction in patients with advanced non-revascularisable coronary artery disease","volume":"26","author":"Colivicchi","year":"2010","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.ijcard.2011.01.033_bb0070","series-title":"European Society of Cardiology, Hot Line Session III","article-title":"PRINCESS: prevention of ischaemic events by early treatment of cerivastatin after acute myocardial infarction","author":"Wright","year":"2004"},{"key":"10.1016\/j.ijcard.2011.01.033_bb0075","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJM200202143460721","article-title":"Cerivastatin and reports of fatal rhabdomyolysis","volume":"346","author":"Staffa","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2011.01.033_bb0080","first-page":"107","article-title":"Time course of serum lipids and apolipoproteins after acute myocardial infarction: modification by pravastatin","volume":"52","author":"Kesteloot","year":"1997","journal-title":"Acta Cardiol"},{"key":"10.1016\/j.ijcard.2011.01.033_bb0085","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.amjcard.2005.11.031","article-title":"Effects of early statin treatment on symptomatic heart failure and ischemic events after acute myocardial infarction in Japanese","volume":"97","author":"Sakamoto","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijcard.2011.01.033_bb0090","first-page":"46","article-title":"The effects of early application of simvastatin on C-reactive protein level, blood lipids, and the clinical course of acutecoronary syndrome","volume":"85","author":"Shal'nev","year":"2007","journal-title":"Klin Med"},{"key":"10.1016\/j.ijcard.2011.01.033_bb0095","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)","volume":"344","author":"Scandinavian Simvastatin Survival Study Group","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2011.01.033_bb0100","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199811053391902","article-title":"Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels","volume":"339","author":"The Long-term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2011.01.033_bb0105","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.ijcard.2011.01.033_bb0110","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/bmj.323.7304.101","article-title":"Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis","volume":"323","author":"Sterne","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.ijcard.2011.01.033_bb0115","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.ijcard.2011.01.033_bb0120","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1161\/01.CIR.99.25.3227","article-title":"Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes. The RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial","volume":"99","author":"Dupuis","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2011.01.033_bb0125","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0002-9149(00)01230-3","article-title":"Beneficial effects of pravastatin (+\/\u2212colestyramine\/niacin) initiated immediately after a coronary event (the randomized Lipid-Coronary Artery Disease [L-CAD] Study)","volume":"86","author":"Arntz","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijcard.2011.01.033_bb0130","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1742-1241.2001.tb11043.x","article-title":"Pravastatin in acute ischaemic syndromes: results of a randomised placebo-controlled trial","volume":"55","author":"Den Hartog","year":"2001","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.ijcard.2011.01.033_bb0135","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2143\/AC.57.4.2005430","article-title":"Early use of pravastatin in patients with acute myocardial infarction undergoing coronary angioplasty","volume":"57","author":"Kayikcioglu","year":"2002","journal-title":"Acta Cardiol"},{"key":"10.1016\/j.ijcard.2011.01.033_bb0140","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1016\/j.ahj.2003.10.052","article-title":"Effect of pravastatin compared with placebo initiated within 24 hours of onset of acute myocardial infarction or unstable angina: the Pravastatin in Acute Coronary Treatment (PACT) trial","volume":"148","author":"Thompson","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.ijcard.2011.01.033_bb0145","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1253\/circj.72.17","article-title":"Effect of early use of low-dose pravastatin on major adverse cardiac events in patients with acute myocardial infarction: the OACIS-LIPID Study","volume":"72","author":"Sato","year":"2008","journal-title":"Circ J"},{"key":"10.1016\/j.ijcard.2011.01.033_bb0150","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/jama.285.13.1711","article-title":"Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial","volume":"285","author":"Schwartz","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2011.01.033_bb0155","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/S0002-9149(02)02711-X","article-title":"Effects of atorvastatin 80mg daily early after onset of unstable angina pectoris or non-Q-wave myocardial infarction","volume":"90","author":"Colivicchi","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijcard.2011.01.033_bb0160","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1161\/01.CIR.0000140261.58966.A4","article-title":"Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study","volume":"110","author":"Okazaki","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2011.01.033_bb0165","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ahj.2004.07.041","article-title":"Atorvastatin has an important acute anti-inflammatory effect in patients with acute coronary syndrome: results of a randomized, double-blind, placebo-controlled study","volume":"149","author":"Macin","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.ijcard.2011.01.033_bb0170","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1001\/jama.287.24.3215","article-title":"Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial","volume":"287","author":"Serruys","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2011.01.033_bb0175","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1053\/euhj.2002.3291","article-title":"Effect of fluvastatin on ischaemia following acute myocardial infarction: a randomized trial","volume":"23","author":"Liem","year":"2002","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijcard.2011.01.033_bb0180","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1745-6215-11-61","article-title":"Fluvastatin in the first-line therapy of acute coronary syndrome: results of the multicenter, randomized, double-blind, placebo-controlled trial (the FACS-trial)","volume":"11","author":"Ostadal","year":"2010","journal-title":"Trials"},{"key":"10.1016\/j.ijcard.2011.01.033_bb0185","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/jama.292.11.1307","article-title":"Early Intensive vs a Delayed Conservative Simvastatin Strategy in Patients With Acute Coronary Syndromes: phase Z of the A to Z Trial","volume":"292","author":"De Lemos","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2011.01.033_bb0190","doi-asserted-by":"crossref","first-page":"E280","DOI":"10.25011\/cim.v32i4.6619","article-title":"Effect of simvastatin on plasma interleukin-6 in patients with unstable angina","volume":"32","author":"Ren","year":"2009","journal-title":"Clin Invest Med"},{"key":"10.1016\/j.ijcard.2011.01.033_bb0195","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0149-2918(00)80066-1","article-title":"Benefits of early lipid-lowering intervention in high-risk patients: the lipid intervention strategies for coronary patients study","volume":"22","author":"Pedersen","year":"2000","journal-title":"Clin Ther"},{"key":"10.1016\/j.ijcard.2011.01.033_bb0200","series-title":"Biostatistical Methods","article-title":"Sample size, power, and efficiency","author":"Lachin","year":"2000"},{"key":"10.1016\/j.ijcard.2011.01.033_bb0205","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0002-9149(02)02443-8","article-title":"Short-term effect of atorvastatin (80mg) on plasma lipids of patients with unstable angina pectoris or non-Q-wave acute myocardial infarction","volume":"90","author":"Correia","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijcard.2011.01.033_bb0210","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2174\/1381612043453360","article-title":"Insights into early and rapid effects of statin therapy after coronary interventions","volume":"10","author":"Walter","year":"2004","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.ijcard.2011.01.033_bb0215","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1016\/S0735-1097(98)00487-2","article-title":"HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis","volume":"32","author":"Bustos","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2011.01.033_bb0220","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(98)05917-0","article-title":"Inhibition of proinflammatory cytokine production by pravastatin","volume":"353","author":"Rosenson","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2011.01.033_bb0225","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1093\/eurheartj\/ehm355","article-title":"Universal definition of myocardial infarction","volume":"28","author":"Thygesen","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijcard.2011.01.033_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta13340","article-title":"Early high-dose lipid-lowering therapy to avoid cardiac events: a systematic review and economic evaluation","volume":"13","author":"Ara","year":"2009","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.ijcard.2011.01.033_bb0235","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jacc.2007.10.001","article-title":"2007 focused update of the ACC\/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"51","author":"Antman","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2011.01.033_bb0240","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2007.02.013","volume":"50","author":"Anderson","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2011.01.033_bb0245","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1001\/jama.288.4.462","article-title":"Adherence with statin therapy in elderly patients with and without acute coronary syndromes","volume":"288","author":"Jackevicius","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2011.01.033_bb0250","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0953-6205(00)00110-2","article-title":"Systematic, immediate in-hospital initiation of lipid-lowering drugs during acute coronary events improves lipid control","volume":"11","author":"Nordmann","year":"2000","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ijcard.2011.01.033_bb0255","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ahj.2004.06.033","article-title":"Early initiation of lipid-lowering therapy for acute coronary syndromes improves compliance with guideline recommendations: observations from the Orbofiban in Patients with Unstable Coronary Syndromes (OPUS-TIMI 16) trial","volume":"149","author":"Smith","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.ijcard.2011.01.033_bb0260","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1001\/jama.297.2.177","article-title":"Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction","volume":"297","author":"Rasmussen","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2011.01.033_bb0265","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1016\/j.jacc.2008.10.012","volume":"52","author":"Krumholz","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2011.01.033_bb0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijcard.2010.07.030","article-title":"Ethics in the authorship and publishing of scientific articles","volume":"144","author":"Shewan","year":"2010","journal-title":"Int J Cardiol"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527311000635?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527311000635?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:30:20Z","timestamp":1759091420000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527311000635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0167527311000635"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2011.01.033","relation":{},"ISSN":["0167-5273"],"issn-type":[{"type":"print","value":"0167-5273"}],"subject":[],"published":{"date-parts":[[2012,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Updated evidence on early statin therapy for acute coronary syndromes: Meta-analysis of 18 randomized trials involving over 14,000 patients","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2011.01.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}